drugset / Trial / NCT03903926
Efficacy Trial of a Commercial EV71 Vaccine
Non-randomizedParallel-groupOpen-labelPrevention
Summary
The purpose of this post-marketing study is to evaluate the efficacy, immunogenicity, and safety of the EV71 vaccine post marketing, and explore the protective levels of various enterovirus neutralizing antibodies
Timeline
- Start
- 2019-03-26
- Primary completion
- 2020-06-30
- Completion
- 2020-10-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | EV71 vaccine | Vaccine | — | — |